Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001078782-20-000233
Filing Date
2020-04-06
Accepted
2020-04-06 16:28:50
Documents
1
Period of Report
2020-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 5267
  Complete submission text file 0001078782-20-000233.txt   6798
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Issuer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 13215 BEE CAVE PARKWAY SUITE 125 GALLERIA OAKS B AUSTIN TX 78738
Business Address
Kway Jasmine (Reporting) CIK: 0001808135 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36833 | Film No.: 20777289